Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02914236 · ClinicalTrials.gov registry record · NA
Treatment of Nasal Airway Obstruction Using the Aerin Medical Device
A NA study, sponsored by Aerin Medical.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02914236: Completed NA study, sponsored by Aerin Medical.
NCT02914236 is a NA study that has completed, run by Aerin Medical. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02914236, a NA study, has completed, sponsored by Aerin Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Evaluation of the Aerin Medical Device used for the treatment of nasal obstruction.
Primary Outcome
Mean change in Nasal Obstruction Symptom Evaluation (NOSE) score from baseline to 26 weeks post-study procedure. Improvement (baseline score - 26-week score) is signified by a positive value. The Nasal Obstruction Symptom Evaluation (NOSE) scale is a validated disease-specific health status outcomes instrument, used to assess severity of nasal obstruction symptoms. Score ranges from 0 to 100. Higher scores indicate increased symptoms/symptom severity.
Interventions
- DEVICE Vivaer Stylus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-09-27 |
| Est. Completion | 2017-08-18 |
| Phase | NA |
What the finished NCT02914236 record still lists
NCT02914236 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Vivaer Stylus is the first listed.
NCT02914236 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02914236 about?
NCT02914236 is a clinical study titled "Treatment of Nasal Airway Obstruction Using the Aerin Medical Device". Evaluation of the Aerin Medical Device used for the treatment of nasal obstruction.
What is the current status of trial NCT02914236?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-09-27. Estimated completion is 2017-08-18.
What interventions are being tested in trial NCT02914236?
The interventions under investigation include: Vivaer Stylus (DEVICE).
Who is sponsoring clinical trial NCT02914236?
This trial is sponsored by Aerin Medical, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02914236's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI